Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial – SYS-CON Media (press release)
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial SYS-CON Media (press release) The therapeutic activity of ApoB SNALP has been demonstrated in preclinical models of high cholesterol. Rodents fed a high fat diet demonstrate a 50-100% ... |

















































